Clinical Trials Directory

Trials / Completed

CompletedNCT07387172

Relationships of B-cell Activating Factor Gene Polymorphisms With Crohn's Disease.

Relationships of B-cell Activating Factor Gene Polymorphisms With the Risk and Clinicopathological Features of Crohn's Disease.

Status
Completed
Phase
Study type
Observational
Enrollment
824 (actual)
Sponsor
Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

From January 2020 to December 2024, Crohn's disease(CD) patients and gender- and age-matched normal controls were collected from the Department of Gastroenterology, the Second Affiliated Hospital of Wenzhou Medical University. The aim of this research is to explore the associations of B-cell activating factor(BAFF) gene polymorphisms with the risk and clinicopathological characteristics of CD.

Detailed description

From January 2020 to December 2024, a total of 310 CD patients and 514 gender- and age-matched normal controls were collected from the Department of Gastroenterology, the Second Affiliated Hospital of Wenzhou Medical University.The genotypes of BAFF were determined by multiplex polymerase chain reaction-ligase detection reaction technique. Unconditional logistic regression was employed to analyze the distribution of BAFF gene polymorphisms between CD group and normal control group, as well as their influences on the clinicopathological characteristics of CD patients.

Conditions

Timeline

Start date
2020-01-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2026-02-04
Last updated
2026-02-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07387172. Inclusion in this directory is not an endorsement.